Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
CureTalks features leading medical experts in conversation with a panel of patients/advocates about latest research and treatments under development.
…
continue reading
The Multiple Myeloma Research Foundation provides educational programs to help people with myeloma, family members, caregivers, and healthcare professionals learn more about the disease and today's most promising treatment options, including clinical trials, from leading multiple myeloma doctors and researchers.
…
continue reading
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
…
continue reading
Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.
…
continue reading
Yo, not to get all heavy on you, but this Podcast was born out of my personal experience as a Black man with cancer. I’ve learned a lot... sooo peep this. Black Americans carry a disproportionate cancer burden, including the highest mortality rates from most cancers, and slowest time to diagnosis of any other race. Not only are Black Americans 41% more likely to die from cancer, but they also top the charts in heart disease, diabetes, and obesity too. So, what’s shaking and taking our lives ...
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
…
continue reading
Welcome to the Clinical Care Solutions Oncology podcast channel. Our podcast shows give you quick access to important content when you need it - at home, at your desk, or on the go.
…
continue reading
Sit back and listen to Ulf-Henrik Mellqvist talking about the significant developments in the field of multiple myeloma treatment. What do the new possibilities mean for patients and doctors? And why should young doctors looking to specialize go into hematology?
…
continue reading
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
…
continue reading
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
…
continue reading
The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.
…
continue reading
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer. Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest ...
…
continue reading
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us ...
…
continue reading
This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth. Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston Tweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk
…
continue reading
HemeTalks: Conversations in Hematology Education is the latest podcast channel by the American Society of Hematology (ASH)! Explore educational content crafted by subject-matter experts from the ASH tailored to fulfill your professional education requirements. Whether you are a clinician or researcher, HemeTalks provides innovative education designed for every career stage and subspecialty.
…
continue reading
Welcome to the mibo show, where we focus on mind and body wellness… let’s talk about it!!! Each episode our guests will talk about their mental and/or physical health journey or that of their family. We will also have subject matter experts talk health facts and stats, best practices for wellness, and provide strategies to encourage us all how to live a healthy lifestyle where we prioritize our mind and body wellness on a regular basis!
…
continue reading
The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.
…
continue reading
Listen to podcasts with key opinion leaders in multiple therapy areas, discussing hot topics including topic overviews, expert opinions and conference overviews. Brought to you by the Adis Journals Group, part of Springer Nature. The primary audience for these podcasts are healthcare professionals, and are published and citable through the journals.
…
continue reading
Wait How Do You Spell That? is a rare disease podcast produced by Patient Worthy. We talk about issues affecting people rare and underdiagnosed conditions and interview advocates from across the community. We‘re definitely not doctors, and we can‘t give you medical advice. We‘re just here to chat and learn about the diseases that even doctors can‘t seem to spell. Check out the latest in rare disease news at PatientWorthy.com.
…
continue reading
"The Author Factor" is the distinctive edge and enhanced credibility that an individual gains by writing and publishing a nonfiction book related to their field of expertise or business. The Author Factor Podcast explores the unique ripple effect and power of nonfiction book authorship to elevate authority, amplify visibility, and create lasting impact. Hosted by book marketing expert and author, Mike Capuzzi, each weekly episode brings you firsthand insights from successful nonfiction autho ...
…
continue reading
The Cancer Revolution podcast series looks to explore all areas of integrative, traditional and alternative means of beating cancer and creating sustained good health, for the young folks and old. Our topics will include areas such as immune system, metabolic theory, epigenetic, microbial connections, diet, mitigating side effects of cancer treatments, detoxification methods, anticancer nutrition, the latest news and stories in institutional cancer research
…
continue reading
Hey everyone! Do you think we can grow a brain outside our body? Welcome to the podcast where we take stem cells very "seriously". We invite everyone who is interested in the topic of stem cells to follow along. We highlight all of the incredible discoveries of stem cells from their origins to their therapeutic applications in modern medicine.Our podcast is friendly, informative, and intrigues curious minds to further our understanding of the complexities of stem cells.
…
continue reading
Bringing you untold stories behind luminaries and legends of the New York City’s running culture. A new show from the CITIUS MAG Podcast Network. Hosted by Leigh Anne Sharek and Chris Chavez. Support us on Patreon: https://patreon.com/runnersofnyc Be sure to check out CITIUSMAG.com for all your latest running commentary. Support the show and rep Runners of NYC: https://www.bonfire.com/runners-of-nyc-podcast/ ▶ Follow us: twitter.com/RunnersOfNYC | Instagram.com/RunnersOfNYC | Facebook.com/Ci ...
…
continue reading
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Cancer Healing Journeys by ZenOnco.io & Love Heals Cancer
Kishan Shah, Vasundhara Raghavan, Nadia Raju, Prabhat Kumar Verma, Imran Shaikh, Vijay Sharnangat, Premitha R, Shreshtha Mittal, Divya Sharma, Bhumi Ben, Divya Par, Farida Rizwan, Asmita Bhattacharya, Sidharth Ghosh
"In life, winning and losing will both happen. What is never acceptable is quitting." When you feel that you are alone in this journey, you really are not alone. There are countless warriors who have gone through a similar journey like what you are going through today; they have felt the immense pain that you are experiencing; but in the end, they have healed themselves from cancer. Some talk about their own journey as you are listening to this, while some have defeated pain forever, but in ...
…
continue reading
The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. If you like to join us as a sponsor or advertisers, download our med ...
…
continue reading
As the leading authoritative, peer-reviewed audio source of oncology clinical news for clinicians and healthcare professionals, the AJO Podcast regularly brings you exclusive interviews with the world's leading researchers and clinicians responsible for pushing out the boundaries of science and practice. Medicine, screening, radiotherapy, surgery, clinical trials, cancer care, epidemiology and prevention are covered impartially to give busy cancer professionals access to conversational spoke ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Patient-Centered Care in Newly Diagnosed Multiple Myeloma: Navigating Triplet and Quadruplet Therapy
32:22
32:22
Play later
Play later
Lists
Like
Liked
32:22
Did you know that choosing between triplet and quadruplet regimens can make a significant difference in achieving optimal disease outcomes? Credit available for this activity expires: 08/19/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001477?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Multiple Myeloma | Jesús G Berdeja, MD
1:00:33
1:00:33
Play later
Play later
Lists
Like
Liked
1:00:33
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma | Faculty Presentation 2: Chimeric Antigen Receptor T-Cell Therapy, Bispecific Antibodies and Antibody-Drug Conjugates for MM — Jesús G Berdeja, MD CME information and select publications…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
1:02:03
1:02:03
Play later
Play later
Lists
Like
Liked
1:02:03
Dr Jesús G Berdeja from the Greco-Hainsworth Tennessee Oncology Centers for Research in Nashville and Dr Thomas Martin from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco discuss the most relevant new data sets and advances in multiple myeloma.By Neil Love, MD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Immune fitness and response to taclistamab in R/R multiple myeloma; BCR::ABL1 M244V mutation causes resistance to asciminib; HSCT and myocardial fibrosis in young patients with SCD
16:59
16:59
Play later
Play later
Lists
Like
Liked
16:59
In this week's episode we’ll discuss how immune fitness impacts response to teclistamab in relapsed/refractory multiple myeloma; learn more about a new mechanism of resistance to asciminib conferred by the BCR::ABL1 M244V mutation, and discuss the impact of hematopoietic cell transplantation on myocardial fibrosis in young patients with sickle cell…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Power of Resiliency, Feat. Multiple Myeloma Patient Advocate Keisha Hickson
50:02
50:02
Play later
Play later
Lists
Like
Liked
50:02
In this episode of the podcast, we speak to professional speaker and community advocate Keisha Hickson, who was diagnosed with multiple myeloma in 2016. That’s a rare form of cancer that develops in a type of white blood cell called a plasma cell. We discuss navigating a rare cancer diagnosis, adjusting to a new normal and the importance of resilie…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Prostate Cancer: It's More Than Just a PSA Thang
52:36
52:36
Play later
Play later
Lists
Like
Liked
52:36
If you're a dude, you've probably heard those dreaded words, "bend over, it's time for your prostate exam" from your doc'. And if you're getting an annual physical, you've likely had your PSA tested, maybe even heard that your number was high. What are you supposed to do? The National Cancer Institute recommends additional testing for a PSA above 4…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Metastatic Breast Cancer | Oncology Today with Dr Neil Love: An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer
45:58
45:58
Play later
Play later
Lists
Like
Liked
45:58
Featuring an interview with Prof Giuseppe Curigliano, including the following topics: Counseling patients with newly diagnosed metastatic breast cancer (mBC); role of patient-reported outcomes and advocacy (0:00) Individualized selection of up-front therapy for patients with HR-positive, HER2-negative mBC (6:02) Selection and sequencing of treatmen…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer
46:12
46:12
Play later
Play later
Lists
Like
Liked
46:12
Prof Giuseppe Curigliano from the European Institute of Oncology in Milano, Italy discusses current questions and controversies in the management of metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.By Research To Practice
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ovarian and Endometrial Cancer | Oncology Today with Dr Neil Love: An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer
52:23
52:23
Play later
Play later
Lists
Like
Liked
52:23
Featuring an interview with Dr Angeles Alvarez Secord, including the following topics: Front-line management of ovarian cancer (0:00) Management of relapsed/refractory ovarian cancer (20:06) Management of microsatellite instability-high/mismatch repair-deficient endometrial cancer (23:20) Management of microsatellite stable/mismatch repair-proficie…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Updates in Thalassemia: New Challenges and Novel Treatment Approaches
20:19
20:19
Play later
Play later
Lists
Like
Liked
20:19
Speakers: Alexis Thompson, MD, and Sujit Sheth, MD Description: For general hematologists with a foundational understanding of thalassemia, this episode discusses the changing demographics due to immigration and refugee resettlement. It covers the diagnosis process from newborn screening to older individuals, emphasizing genetic testing due to nume…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Protective role of neonatal CMV infection in B-ALL; GVHD targets organoid-forming bile duct stem cells; seven-year outcomes for venetoclax-ibrutinib therapy in MCL
16:56
16:56
Play later
Play later
Lists
Like
Liked
16:56
In this week's episode we'll learn how cytomegalovirus infection early in life depletes preleukemic cells in a mouse model of B-cell acute lymphoblastic leukemia. After that we'll discuss new research, where GVHD targets organoid-forming bile duct stem cells in a TGF-beta-dependent manner. Conversely, a TGF-beta inhibitor protects these stem cells …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Marilyn Jenkins: The Google Business Profile Training Guide
22:10
22:10
Play later
Play later
Lists
Like
Liked
22:10
On episode #242 of The Author Factor Podcast, I am having a conversation with nonfiction book author Marilyn Jenkins. Marilyn is a seasoned digital marketing expert with over 16 years of experience. She is the founder of MJ Media Group and Law Marketing Zone. Her expertise in leveraging paid advertising and SEO, particularly for optimizing Google B…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Key Takeaways From 2024 ASCO Breakthrough
14:26
14:26
Play later
Play later
Lists
Like
Liked
14:26
Dr. Lillian Siu and Dr. Melvin Chua discuss the new technologies and novel therapeutics that were featured at the 2024 ASCO Breakthrough meeting. TRANSCRIPT Dr. Lillian Siu: Hello and welcome to the ASCO Daily News Podcast. I'm Dr. Lillian Siu, a medical oncologist and director of the Phase 1 Trials Program at the Princess Margaret Cancer Center in…
…
continue reading
In this episode of the mibo show, Shanti Das speaks with actress Jenifer Lewis about her battle with bipolar disorder and depression. This episode took place on location in Chicago at the Black Women’s Expo. Lewis said she first sought out mental health help during the AIDS epidemic when she saw her best friend covered in lesions due to the disease…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Non-Small Cell Lung Cancer | Professor Solange Peters, MD, PhD
39:01
39:01
Play later
Play later
Lists
Like
Liked
39:01
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer | Faculty Presentation 1: Significance of Biomarker Testing in Localized Non-Small Cell Lung Cancer (NSCLC) and Historical Management Paradigm for ALK-Positive Disease — Professor Solange Peters, MD, PhD CME information and select publicat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Non-Small Cell Lung Cancer | Professor Ben Solomon, MBBS, PhD
21:43
21:43
Play later
Play later
Lists
Like
Liked
21:43
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer | Faculty Presentation 2: Emerging Role and Practical Application of ALK-Targeted Therapy in Localized NSCLC — Professor Ben Solomon, MBBS, PhD CME information and select publicationsBy Dr. Neil Love
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Non-Small Cell Lung Cancer | Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
1:01:24
1:01:24
Play later
Play later
Lists
Like
Liked
1:01:24
Featuring perspectives from Prof Solange Peters and Prof Ben Solomon, including the following topics: Introduction (0:00) Significance of Biomarker Testing in Localized Non-Small Cell Lung Cancer (NSCLC) and Historical Management Paradigm for ALK-Positive Disease — Prof Peters (9:17) Emerging Role and Practical Application of ALK-Targeted Therapy i…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer
52:36
52:36
Play later
Play later
Lists
Like
Liked
52:36
Dr Angeles Alvarez Secord from the Duke Cancer Institute in Durham, North Carolina, provides her perspectives on recent datasets from ASCO 2024 on the management of ovarian and endometrial cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
1:01:23
1:01:23
Play later
Play later
Lists
Like
Liked
1:01:23
Prof Solange Peters from the Lausanne University Hospital in Lausanne, Switzerland, and Professor Ben Solomon from the Peter MacCallum Cancer Centre in Melbourne, Australia, discuss treatment approaches for ALK-rearranged non-small cell lung cancer in the localized disease setting, moderated by Dr Neil Love. Produced by Research To Practice. CME in…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Hemophilia updates from ISTH 2024: ongoing clinical trials, emerging gene therapies & remaining challenges
18:41
18:41
Play later
Play later
Lists
Like
Liked
18:41
This week's VJHemOnc podcast brings you updates in hemophilia from the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Bangkok, Thailand, and virtually. You hear from experts Omolade Awodu, MBChB, MD, FMCPath, University of Benin, Benin City, Nigeria, who discusses key hemophilia clinical trials in 2024, Rad…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Breast Cancer | Oncology Today with Dr Neil Love: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
54:03
54:03
Play later
Play later
Lists
Like
Liked
54:03
Featuring perspectives from Dr Sara A Hurvitz, including the following topics: Case: A woman in her late 40s who received treatment for triple-negative breast cancer develops lung metastases 2 years later (0:00) Clinical trials investigating TROP2-targeting antibody-drug conjugates (13:28) Identifying and targeting HER2 in HER2 low-expressing disea…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Selecting Antiseizure Medications and Aiming for Seizure Freedom
38:05
38:05
Play later
Play later
Lists
Like
Liked
38:05
How to achieve seizure freedom after 2 antiseizure medications (ASMs) fail? Expert insight into best practice Credit available for this activity expires: 8/15/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001425?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Advances in Dermal Fillers: Hybrid Fillers and the Power of Regenerative Biostimulation
32:15
32:15
Play later
Play later
Lists
Like
Liked
32:15
Learn the fundamentals of regenerative aesthetics and how hybrid fillers can help you achieve patient goals. Credit available for this activity expires: 8/15/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001440?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
54:17
54:17
Play later
Play later
Lists
Like
Liked
54:17
Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes recent trials investigating the integration of antibody-drug conjugates for HR-positive and triple-negative metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Iron, HFE haemochromatosis, and infections; bispecific antibodies improve CAR T-cell response; determinants of outcome in NPM1-mutated AML
23:31
23:31
Play later
Play later
Lists
Like
Liked
23:31
In this week's episode we'll learn about iron, HFE hemochromatosis, and infections. In this large, population-based study, both high and low levels of plasma iron and transferrin saturation were associated with increased risks of infection. Then, we'll discuss how bispecific antibodies improve CAR T-cell response in B-cell malignancies. In-vitro an…
…
continue reading
On episode #241 of The Author Factor Podcast, I am having a conversation with nonfiction book author Eric Gee. Eric has administered personality-based life coaching for more than 20 years and has created the Utopia project website and Utopia 16 assessment, which has reached over half a million users since 2016. He recently published his first book,…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How AI Can Improve Patient Identification and Recruitment for Clinical Trials
18:20
18:20
Play later
Play later
Lists
Like
Liked
18:20
Dr. Shaalan Beg and Dr. Arturo Loaiza-Bonilla discuss the potential of artificial intelligence to assist with patient recruitment and clinical trial matching using real-world data and next-generation sequencing results. TRANSCRIPT Dr. Shaalan Beg: Hello, and welcome to the ASCO Daily News Podcast. I'm Dr. Shaalan Beg, your guest host for the podcas…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Myeloma Matters: Bispecific Antibody Horizons: Dosing Strategies and Meeting Updates in Myeloma Care
Host: Saad Z. Usmani, MD, MBA, FACP Guest: Joshua Richter, MD Guest: Ashley Steinberger, APP Release date: 8/15/2024 Expiration date: 8/15/2025 Estimated time to complete: 1.0 hour This activity is not accredited for CME/CE credit. This episode of Myeloma Matters reviews the latest data on bispecific antibody therapy for relapsed/refractory multipl…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Lung Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Lung Cancer
1:01:44
1:01:44
Play later
Play later
Lists
Like
Liked
1:01:44
Featuring perspectives from Dr Melissa Johnson, Dr Ticiana Leal and Dr Manish Patel, including the following topics: Introduction: Two Faces of Lung Cancer Research (0:00) B7-H3-Targeted Antibody-Drug Conjugates for Lung Cancer — Dr Patel (16:14) Potential Role of Tumor Treating Fields in the Management of Metastatic Non-Small Cell Lung Cancer — Dr…
…
continue reading